Suppliers / Cadila Healthcare

Cadila Healthcare

India 5 duplicate records merged Updated 9 July 2026

Cadila Healthcare is an API and finished-dose manufacturer based in India. It appears in 147 regulatory filings across 7 regulators, without an active US DMF or CEP on file. Its filings concentrate with DAV (Vietnam), TMDA (TZ) and MINSA (CR). Its GMP standing is certified by CDSCO (India) and EMA. Customs aggregates show $991.9M of exports covering 11,041 molecules to 79 destinations in 2025.

0
active US DMFs
0
valid CEPs
9
registered plants
147
filings across 7 regulators
These figures were checked against the regulators' own files on 25 July 2026
EU GMP
1 of 1 confirmed
Sources: EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Registered plants

Site FDA FEI
Ankleshwar, India Not on file
vatva ahmedabad ahmedabad, India Not on file
tal sanand moraiya 382 210 ahmedabad, India Not on file
ankleshwar 393 002 bharuch, India Not on file
tal padra dabhasa 391 440 vadodara, India Not on file
tal sanand changodar 382 213 ahmedabad, India Not on file

3 further sites are on record.

What they file, and where

Molecule Regulators Docs
Amlodipine SFDA (Saudi Arabia) 1
Atorvastatin SFDA (Saudi Arabia) 1
Candesartan Cilexetil SFDA (Saudi Arabia) 1
Clopidogrel SFDA (Saudi Arabia) 1
Empagliflozin SFDA (Saudi Arabia) 1
Etoricoxib SFDA (Saudi Arabia) 1
Famotidine SFDA (Saudi Arabia) 1
Hydrous Benzoyl Peroxide SFDA (Saudi Arabia) 1
Ivabradine SFDA (Saudi Arabia) 1
Levofloxacin SFDA (Saudi Arabia) 1
Show all 14 molecules on file
Olmesartan Medoximil SFDA (Saudi Arabia) 1
Paroxetine SFDA (Saudi Arabia) 1
Tamsolusin SFDA (Saudi Arabia) 1
Tirofiban SFDA (Saudi Arabia) 1

Also appears on these molecule pages

Adapalene finished dose Candesartan Cilexetil API Etoricoxib API Famotidine API Ivabradine API Paroxetine API Raloxifene finished dose Tirofiban API Warfarin finished dose Amlodipine API Atorvastatin API Clopidogrel API
Show 2 more molecule pages
Empagliflozin API Levofloxacin API

Filings and GMP by regulator

Regulator Filings GMP certificates
DAV (Vietnam) 100 None
TMDA (TZ) 22 None
MINSA (CR) 10 None
ZAMRA (ZM) 6 None
ARCSA (EC) 4 None
COFEPRIS (MX) 3 None
CDSCO (India) None 6
EMA None 1

Scale

Year Revenue Exports Destinations
2026 YTD Not reported $58.4M 37
2025 Not reported $991.9M 79
2024 Not reported $1.3B 71
2023 Not reported $897.8M 77

Export figures are customs aggregates. We do not publish the identity of any buyer.

Questions about Cadila Healthcare

Does Cadila Healthcare hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Cadila Healthcare. It does have 147 filings with 7 regulators, so it is registered, just not with the two strong registers buyers usually screen on.
Where does Cadila Healthcare manufacture?
9 registered sites are on record, in India (Ankleshwar, Vatva Ahmedabad Ahmedabad and Tal Sanand Moraiya 382 210 Ahmedabad among others). Every site is listed on this page with the register it came from.
What does Cadila Healthcare make?
14 molecules are on record against Cadila Healthcare, including Amlodipine, Atorvastatin, Candesartan Cilexetil and Clopidogrel. Each links through to that molecule's full manufacturer list.
Which regulators recognise Cadila Healthcare's GMP?
Current GMP certificates are on record from CDSCO (India) and EMA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Cadila Healthcare comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Alembic Pharmaceuticals shares 4 molecules Hetero shares 3 molecules Zydus Lifesciences shares 3 molecules Apitoria Pharma shares 2 molecules Ipca Laboratories shares 2 molecules

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Customs aggregates
Export values, molecule and destination counts